Safety and pharmacokinetics of bimagrumab in healthy older and obese adults with body composition changes in the older cohort
出版年份 2020 全文链接
标题
Safety and pharmacokinetics of bimagrumab in healthy older and obese adults with body composition changes in the older cohort
作者
关键词
-
出版物
Journal of Cachexia Sarcopenia and Muscle
Volume 11, Issue 6, Pages 1525-1534
出版商
Wiley
发表日期
2020-12-03
DOI
10.1002/jcsm.12639
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The Importance of Resistance Exercise Training to Combat Neuromuscular Aging
- (2019) Kaleen M. Lavin et al. PHYSIOLOGY
- Growth differentiation factor 11 (GDF11) has pronounced effects on skin biology
- (2019) Jolanta Idkowiak-Baldys et al. PLoS One
- Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial
- (2019) Michael G Hanna et al. LANCET NEUROLOGY
- Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle : update 2019
- (2019) Stephan Haehling et al. Journal of Cachexia Sarcopenia and Muscle
- Effects of bimagrumab, an activin receptor type II inhibitor, on pituitary neurohormonal axes
- (2018) Tania Garito et al. CLINICAL ENDOCRINOLOGY
- Advanced body composition assessment: from body mass index to body composition profiling
- (2018) Magnus Borga et al. JOURNAL OF INVESTIGATIVE MEDICINE
- Activin Type II Receptor Blockade for Treatment of Muscle Depletion in COPD: A Randomized Trial
- (2018) Michael I Polkey et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- High-Intensity Resistance and Impact Training Improves Bone Mineral Density and Physical Function in Postmenopausal Women With Osteopenia and Osteoporosis: The LIFTMOR Randomized Controlled Trial
- (2017) Steven L Watson et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Treatment of Sarcopenia with Bimagrumab: Results from a Phase II, Randomized, Controlled, Proof-of-Concept Study
- (2017) Daniel Rooks et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Blockade of activin type II receptors with a dual anti-ActRIIA/IIB antibody is critical to promote maximal skeletal muscle hypertrophy
- (2017) Frederic Morvan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effect of bimagrumab on thigh muscle volume and composition in men with casting-induced atrophy
- (2017) Daniel S. Rooks et al. Journal of Cachexia Sarcopenia and Muscle
- Dose–Response Relationships of Resistance Training in Healthy Old Adults: A Systematic Review and Meta-Analysis
- (2015) Ron Borde et al. SPORTS MEDICINE
- Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial
- (2015) Clemens Becker et al. Lancet Diabetes & Endocrinology
- Treatment of sporadic inclusion body myositis with bimagrumab
- (2014) A. A. Amato et al. NEUROLOGY
- An Antibody Blocking Activin Type II Receptors Induces Strong Skeletal Muscle Hypertrophy and Protects from Atrophy
- (2013) E. Lach-Trifilieff et al. MOLECULAR AND CELLULAR BIOLOGY
- A single ascending-dose study of muscle regulator ace-031 in healthy volunteers
- (2012) Kenneth M. Attie et al. MUSCLE & NERVE
- Clinical Pharmacokinetics of Therapeutic Monoclonal Antibodies
- (2010) Ron J. Keizer et al. CLINICAL PHARMACOKINETICS
- Regulation of Muscle Mass by Follistatin and Activins
- (2010) Se-Jin Lee et al. MOLECULAR ENDOCRINOLOGY
- Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size
- (2009) Anne Ulrike Trendelenburg et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation